{"id":5983,"date":"2025-03-24T15:02:16","date_gmt":"2025-03-24T20:02:16","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5983"},"modified":"2025-07-13T15:10:10","modified_gmt":"2025-07-13T20:10:10","slug":"nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2025\/03\/24\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u306e\u8996\u529b\u56de\u5fa9\u306b\u95a2\u3059\u308b\u81e8\u5e8a\u30c7\u30fc\u30bf\u306e\u516c\u8868\u3092\u767a\u8868"},"content":{"rendered":"
\n
\n
\n
\n
\n

<\/h1>\n<\/div>\n
\n
\n

\u30c0\u30e9\u30b9<\/span><\/span>,\u00a02025\u5e743\u670824\u65e5<\/span><\/span> \u2014 \u7814\u7a76\u8005\u305f\u3061\u306f\u00a0\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e<\/a>\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308b\u65b0\u3057\u3044\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u958b\u767a\u3068\u5546\u54c1\u5316\u306b\u3088\u308a\u3001\u73fe\u5b9f\u4e16\u754c\u3067\u5931\u660e\u3057\u305f\u60a3\u8005\u306e\u8996\u529b\u56de\u5fa9\u306b\u53d6\u308a\u7d44\u3093\u3067\u3044\u308b\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b\u540c\u793e\u306f\u3001\u8ad6\u6587\u3092\u767a\u8868\u3057\u305f\u3002\u00a0\u201c\u300c\u5408\u6210\u30aa\u30d7\u30b7\u30f3\u304c\u91cd\u5ea6\u306e\u7db2\u819c\u5909\u6027\u75c7\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u300d\u201d<\/b><\/a>\u00a0\u3067\u00a0\u5206\u5b50\u7642\u6cd5\u3001\u00a0<\/i>\u7c73\u56fd\u907a\u4f1d\u5b50\u30fb\u7d30\u80de\u6cbb\u7642\u5b66\u4f1a\u306e\u4e3b\u8981\u5b66\u8853\u8a8c\u306b\u63b2\u8f09\u3055\u308c\u305f\u3053\u306e\u8ad6\u6587\u306f\u3001\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306b\u5bfe\u3059\u308b\u3001\u907a\u4f1d\u5b50\u5909\u7570\u306b\u4f9d\u5b58\u3057\u306a\u3044\u5149\u907a\u4f1d\u5b66\u7684\u5358\u72ec\u7642\u6cd5\u306b\u304a\u3051\u308b\u5927\u304d\u306a\u30d6\u30ec\u30fc\u30af\u30b9\u30eb\u30fc\u3068\u306a\u308b\u3082\u306e\u3067\u3059\u3002.<\/p>\n

\u201c\u300c\u9032\u884c\u6027\u3067\u6c38\u7d9a\u7684\u306a\u5149\u53d7\u5bb9\u4f53\u306e\u55aa\u5931\u304c\u3042\u308a\u3001\u4ed6\u306b\u6cbb\u7642\u306e\u9078\u629e\u80a2\u304c\u306a\u3044\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u60a3\u8005\u306b\u898b\u3089\u308c\u308b\u6cbb\u7642\u52b9\u679c\u306b\u3001\u79c1\u305f\u3061\u306f\u8208\u596e\u3057\u3066\u3044\u307e\u3059\u300d\u3068\u533b\u5e2b\u306f\u8ff0\u3079\u305f\u3002.\u00a0\u30b5\u30f3\u30c8\u30b7\u30e5\u30fb\u30de\u30cf\u30d1\u30c8\u30e9<\/span>\u3053\u306e\u7814\u7a76\u306e\u4e3b\u4efb\u7814\u7a76\u8005\u3067\u3042\u308a\u3001\u30aa\u30ea\u30c3\u30b5\u5ddeJPM\u30ed\u30fc\u30bf\u30ea\u30fc\u773c\u79d1\u75c5\u9662\u306e\u6700\u9ad8\u533b\u7642\u8cac\u4efb\u8005\u3067\u3042\u308b\u00a0\u30a4\u30f3\u30c9<\/span>. \u300c\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u3088\u308b\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u306b\u82e6\u3057\u3080\u65b9\u3005\u3092\u652f\u63f4\u3059\u308b\u305f\u3081\u3001\u3053\u306e\u6280\u8853\u3092\u3055\u3089\u306b\u767a\u5c55\u3055\u305b\u3066\u3044\u304f\u3053\u3068\u3092\u671f\u5f85\u3057\u3066\u3044\u307e\u3059\u3002\u300d\u201c<\/p>\n

\u907a\u4f1d\u6027\u7db2\u819c\u5909\u6027\u75be\u60a3 (IRD) \u306f\u3001\u4e16\u754c\u4e2d\u306e\u52b4\u50cd\u5e74\u9f62\u306e\u6210\u4eba\u306e\u5931\u660e\u306e\u4e3b\u306a\u539f\u56e0\u3067\u3042\u308a\u3001\u9032\u884c\u3059\u308b\u3068\u7d30\u80de\u304c\u5931\u308f\u308c\u3066\u907a\u4f1d\u5b50\u7de8\u96c6\u3084\u7f6e\u63db\u304c\u7121\u52b9\u306b\u306a\u308a\u307e\u3059\u3002\u30aa\u30d7\u30c8\u30b8\u30a7\u30cd\u30c6\u30a3\u30af\u30b9\u306f\u3001\u6b8b\u5b58\u3059\u308b\u7db2\u819c\u30cb\u30e5\u30fc\u30ed\u30f3\u3092\u5149\u611f\u4f5c\u3059\u308b\u3053\u3068\u3067\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u6cbb\u7642\u306e\u6a5f\u4f1a\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u73fe\u5728\u306e\u30aa\u30d7\u30b7\u30f3\u306f\u904b\u52d5\u304c\u9045\u304f\u3001\u5468\u56f2\u5149\u3067\u90e8\u5206\u7684\u306b\u6d3b\u6027\u5316\u3055\u308c\u3001\u3055\u307e\u3056\u307e\u306a\u5149\u306e\u8272\u306b\u53cd\u5fdc\u305b\u305a\u3001\u4f4e\u89e3\u50cf\u5ea6\u306e\u7db2\u819c\u7d30\u80de\u56de\u8def\u3092\u30bf\u30fc\u30b2\u30c3\u30c8\u306b\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u5236\u9650\u3092\u514b\u670d\u3059\u308b\u305f\u3081\u306b\u3001Nanoscope \u30c1\u30fc\u30e0\u306f\u3001\u9078\u629e\u7684\u306b\u5909\u7570\u3055\u305b\u305f 3 \u3064\u306e\u975e\u54fa\u4e73\u985e\u30bf\u30f3\u30d1\u30af\u8cea\u304b\u3089\u306a\u308b\u30b7\u30f3\u30c8\u30d7\u30b7\u30f3\u3092\u8a2d\u8a08\u3057\u3001\u5e83\u5e2f\u57df\u306e\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3 (MCO) \u3092\u5b9f\u73fe\u3057\u307e\u3057\u305f\u3002<\/p>\n

\u201c\u300c\u3053\u306e\u8ad6\u6587\u306f\u3001\u6700\u3082\u6cbb\u7642\u30cb\u30fc\u30ba\u304c\u6e80\u305f\u3055\u308c\u3066\u3044\u306a\u3044\u60a3\u8005\u306b\u5bfe\u3059\u308b\u52b9\u679c\u7684\u306a\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u306b\u304a\u3051\u308b\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30c1\u30fc\u30e0\u306e\u5353\u8d8a\u3057\u305f\u696d\u7e3e\u3092\u5f37\u8abf\u3059\u308b\u3082\u306e\u3067\u3059\u300d\u3068\u535a\u58eb\u306f\u8ff0\u3079\u305f\u3002.\u00a0\u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3<\/span>, \u8ad6\u6587\u306e\u7b46\u982d\u8457\u8005\u3067\u3042\u308a\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u793e\u9577\u3067\u3082\u3042\u308b\u4eba\u7269\u306f\u3001\u300c\u672c\u8ad6\u6587\u3067\u6982\u8aac\u3057\u305f\u5f53\u793e\u306e\u7b2c1\/2a\u76f8\u81e8\u5e8a\u8a66\u9a13\u306e\u826f\u597d\u306a\u7d50\u679c\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u306b\u304a\u3051\u308b\u7121\u4f5c\u70ba\u5316\u6bd4\u8f03\u8a66\u9a13\u306e\u30c7\u30fc\u30bf\u3068\u4f75\u305b\u3066\u3001\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u306e\u6cbb\u7642\u306b\u304a\u3051\u308b\u5927\u304d\u306a\u524d\u9032\u3092\u610f\u5473\u3059\u308b\u300d\u3068\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u201c<\/p>\n

\u6539\u826f\u3055\u308c\u305f\u30b7\u30f3\u30c8\u30d7\u30b7\u30f3\u306f\u3001\u30d2\u30c8\u7db2\u819c\u53cc\u6975\u7d30\u80de\u3092\u6a19\u7684\u3068\u3059\u308b\u6700\u9069\u5316\u3055\u308c\u305fAAV2\u907a\u4f1d\u5b50\u6cbb\u7642\u30d9\u30af\u30bf\u30fc\u306b\u30d1\u30c3\u30b1\u30fc\u30b8\u30f3\u30b0\u3055\u308c\u307e\u3057\u305f\u3002\u7814\u7a76\u8005\u4e3b\u5c0e\u306e\u30aa\u30fc\u30d7\u30f3\u30e9\u30d9\u30eb\u8a66\u9a13\u3067\u306f\u3001\u00a0ABCA4<\/i>\u00a0\u5909\u7570\u578b\u60a3\u8005\u306f\u3001\u785d\u5b50\u4f53\u5185\u907a\u4f1d\u5b50\u6cbb\u7642\u6ce8\u5c04\u30921\u56de\u53d7\u3051\u307e\u3057\u305f\u3002\u975e\u4fb5\u8972\u6027\u753b\u50cf\u8a3a\u65ad\u306b\u3088\u308a\u3001\u86cd\u5149\u30ec\u30dd\u30fc\u30bf\u30fc\u30bf\u30f3\u30d1\u30af\u8cea\u3092\u4ecb\u3057\u305f\u7db2\u819c\u907a\u4f1d\u5b50\u767a\u73fe\u304c\u78ba\u8a8d\u3055\u308c\u307e\u3057\u305f\u3002\u60a3\u8005\u306f\u300152\u9031\u9593\u306e\u7814\u7a76\u671f\u9593\u3092\u901a\u3058\u3066\u8996\u529b\u3001\u5f62\u72b6\u8b58\u5225\u3001\u304a\u3088\u3073\u904b\u52d5\u80fd\u529b\u306e\u6539\u5584\u3092\u793a\u3057\u307e\u3057\u305f\u3002\u3053\u308c\u306f\u3001\u304a\u305d\u3089\u304f\u30d2\u30c8\u3067\u3053\u308c\u307e\u3067\u306b\u767a\u73fe\u3057\u305f\u4e2d\u3067\u6700\u3082\u5408\u6210\u3055\u308c\u305f\u975e\u54fa\u4e73\u985e\u30bf\u30f3\u30d1\u30af\u8cea\u306e1\u3064\u3067\u3042\u308b\u306b\u3082\u304b\u304b\u308f\u3089\u305a\u3001\u5b89\u5168\u6027\u306b\u95a2\u3059\u308b\u91cd\u5927\u306a\u554f\u984c\u306f\u3042\u308a\u307e\u305b\u3093\u3067\u3057\u305f\u3002\u3053\u308c\u306f\u3001\u30aa\u30d7\u30c8\u30b8\u30a7\u30cd\u30c6\u30a3\u30af\u30b9\u6280\u8853\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u4f7f\u7528\u3057\u3066\u3001\u5909\u7570\u306b\u4f9d\u5b58\u3057\u306a\u3044\u65b9\u6cd5\u3067\u5931\u660e\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3067\u304d\u308b\u907a\u4f1d\u5b50\u5358\u72ec\u7642\u6cd5\u306b\u95a2\u3059\u308b\u6700\u521d\u306e\u5831\u544a\u3067\u3059\u3002<\/p>\n

\u201c\u300c\u79c1\u305f\u3061\u306e\u7814\u7a76\u306f\u3001\u907a\u4f1d\u6027\u7db2\u819c\u5909\u6027\u75c7\u306e\u6cbb\u7642\u306b\u304a\u3051\u308b\u91cd\u8981\u306a\u30de\u30a4\u30eb\u30b9\u30c8\u30fc\u30f3\u3067\u3042\u308a\u3001\u5149\u907a\u4f1d\u5b66\u304c\u907a\u4f1d\u5b50\u5909\u7570\u306e\u7a2e\u985e\u306b\u95a2\u308f\u3089\u305a\u3001\u76f2\u76ee\u306e\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3067\u304d\u308b\u3053\u3068\u3092\u5b9f\u8a3c\u3057\u307e\u3057\u305f\u300d\u3068\u535a\u58eb\u306f\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002.\u00a0\u30f4\u30a3\u30cb\u30c3\u30c8\u30fbB\u30fb\u30de\u30cf\u30b8\u30e3\u30f3<\/span>, \u5171\u540c\u8cac\u4efb\u8457\u8005\u3067\u3042\u308a\u3001\u30b9\u30bf\u30f3\u30d5\u30a9\u30fc\u30c9\u5927\u5b66\u773c\u79d1\u6559\u6388\u517c\u7814\u7a76\u62c5\u5f53\u526f\u90e8\u9577\u306f\u3001\u300c\u785d\u5b50\u4f53\u5185\u6ce8\u5c041\u56de\u3067\u8996\u529b\u3092\u56de\u5fa9\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u3063\u305f\u3053\u3068\u306f\u3001\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308b\u666e\u904d\u7684\u306a\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u306b\u5411\u3051\u305f\u91cd\u8981\u306a\u4e00\u6b69\u3068\u306a\u308b\u300d\u3068\u8ff0\u3079\u3066\u3044\u308b\u3002\u201c<\/p>\n

\u81e8\u5e8a\u7814\u7a76\u306e\u5168\u6587\u8ad6\u6587\u3068\u30b0\u30e9\u30d5\u8868\u73fe\u306b\u30a2\u30af\u30bb\u30b9\u3059\u308b\u306b\u306f\u3001\u3053\u3053\u3092\u30af\u30ea\u30c3\u30af\u3057\u3066\u304f\u3060\u3055\u3044\u3002<\/a><\/p>\n

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306b\u3064\u3044\u3066
<\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u73fe\u5728\u6cbb\u7642\u6cd5\u304c\u306a\u3044\u7db2\u819c\u5909\u6027\u75be\u60a3\u3067\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u306e\u305f\u3081\u306b\u3001\u5909\u7570\u306b\u4f9d\u5b58\u3057\u306a\u3044\u8996\u529b\u56de\u5fa9\u30aa\u30d7\u30c8\u30b8\u30a7\u30cd\u30c6\u30a3\u30c3\u30af\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308bRESTORE\u30d5\u30a7\u30fc\u30ba2b\u591a\u65bd\u8a2d\u30e9\u30f3\u30c0\u30e0\u5316\u4e8c\u91cd\u76f2\u691c\u507d\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\u306e\u826f\u597d\u306a\u8a66\u9a13\u7d42\u4e86\u7d50\u679c\u3092\u53d7\u3051\u3066\uff08NCT04945772<\/a>\uff09\u3001\u540c\u793e\u306f\u3001\u00a0RP\u6cbb\u7642\u85acMCO-010\u306eBLA\u7533\u8acb<\/a>\u00a0\u540c\u793e\u306f\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fMCO-010\u7642\u6cd5\u306e\u7b2c2\u76f8STARLIGHT\u8a66\u9a13\u3092\u5b8c\u4e86\u3057\u305f\uff08NCT05417126<\/a>\uff09\u3092\u958b\u59cb\u3057\u3001\u00a0\u30d5\u30a7\u30fc\u30ba3\u767b\u9332\u8a66\u9a13<\/a>\u3001\u540c\u3058\u304f2025\u5e74\u4e0a\u534a\u671f\u306b\u767a\u58f2\u4e88\u5b9a\u3067\u3059\u3002MCO-010\u306f\u3001RP\u3068Stargardt\u306e\u4e21\u65b9\u3067FDA\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u3068FDA\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u306f\u3001IND\u5bfe\u5fdc\u306eGA\u5411\u3051\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u30ec\u30fc\u30b6\u30fc\u9001\u9054MCO-020\u8cc7\u7523\u3068\u3001IND\u5bfe\u5fdc\u7814\u7a76\u4e2d\u306eLeber\u5148\u5929\u6027\u9ed2\u5185\u969c\u5411\u3051AAV\u8cc7\u7523\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n

\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/b>
\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba
212-600-1902
PR@nanostherapeutics.com<\/a><\/p>\n

\u51fa\u5178 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

DALLAS,\u00a0March 24, 2025 \u2014\u00a0Researchers with\u00a0Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal degenerative diseases, have announced the publication of a paper,\u00a0\u201cA synthetic opsin restores vision in patients with severe retinal degeneration,\u201d\u00a0in\u00a0Molecular Therapy,\u00a0the flagship journal of the American Society of Gene & Cell Therapy.\u00a0 The publication of the paper marks a major breakthrough in mutation-independent optogenetic monotherapy for patients suffering from inherited retinal diseases. \u201cWe are excited by the therapeutic benefits seen in retinitis pigmentosa patients with progressive and permanent loss of photoreceptors and without any treatment option,\u201d said Dr.\u00a0Santosh Mahapatra, the principal investigator […]<\/p>\n","protected":false},"author":6,"featured_media":5986,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5983","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"\nNanoscope Announces Publication of Clinical Data on Vision Restoration in Retinitis Pigmentosa - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2025\/03\/24\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Announces Publication of Clinical Data on Vision Restoration in Retinitis Pigmentosa - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2025\/03\/24\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-24T20:02:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-13T20:10:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_MOLECULARTHERAPY_V1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_MOLECULARTHERAPY_V1.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"4\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/24\\\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/24\\\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Announces Publication of Clinical Data on Vision Restoration in Retinitis Pigmentosa\",\"datePublished\":\"2025-03-24T20:02:16+00:00\",\"dateModified\":\"2025-07-13T20:10:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/24\\\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\\\/\"},\"wordCount\":660,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/24\\\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_LI_MOLECULARTHERAPY_REV-for-Web.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/24\\\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/24\\\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\\\/\",\"name\":\"Nanoscope Announces Publication of Clinical Data on Vision Restoration in Retinitis Pigmentosa - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/24\\\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/24\\\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_LI_MOLECULARTHERAPY_REV-for-Web.jpg\",\"datePublished\":\"2025-03-24T20:02:16+00:00\",\"dateModified\":\"2025-07-13T20:10:10+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/24\\\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/24\\\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/24\\\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_LI_MOLECULARTHERAPY_REV-for-Web.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_LI_MOLECULARTHERAPY_REV-for-Web.jpg\",\"width\":1200,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/24\\\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Announces Publication of Clinical Data on Vision Restoration in Retinitis Pigmentosa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u306b\u304a\u3051\u308b\u8996\u529b\u56de\u5fa9\u306b\u95a2\u3059\u308b\u81e8\u5e8a\u30c7\u30fc\u30bf\u306e\u767a\u8868\u3092\u767a\u8868 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2025\/03\/24\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Announces Publication of Clinical Data on Vision Restoration in Retinitis Pigmentosa - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2025\/03\/24\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2025-03-24T20:02:16+00:00","article_modified_time":"2025-07-13T20:10:10+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_MOLECULARTHERAPY_V1.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_MOLECULARTHERAPY_V1.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"4\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2025\/03\/24\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/24\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Announces Publication of Clinical Data on Vision Restoration in Retinitis Pigmentosa","datePublished":"2025-03-24T20:02:16+00:00","dateModified":"2025-07-13T20:10:10+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/24\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\/"},"wordCount":660,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/24\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_MOLECULARTHERAPY_REV-for-Web.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2025\/03\/24\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\/","url":"https:\/\/nanostherapeutics.com\/2025\/03\/24\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u306b\u304a\u3051\u308b\u8996\u529b\u56de\u5fa9\u306b\u95a2\u3059\u308b\u81e8\u5e8a\u30c7\u30fc\u30bf\u306e\u767a\u8868\u3092\u767a\u8868 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/24\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/24\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_MOLECULARTHERAPY_REV-for-Web.jpg","datePublished":"2025-03-24T20:02:16+00:00","dateModified":"2025-07-13T20:10:10+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/24\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2025\/03\/24\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2025\/03\/24\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_MOLECULARTHERAPY_REV-for-Web.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_MOLECULARTHERAPY_REV-for-Web.jpg","width":1200,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2025\/03\/24\/nanoscope-announces-publication-of-clinical-data-on-vision-restoration-in-retinitis-pigmentosa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Announces Publication of Clinical Data on Vision Restoration in Retinitis Pigmentosa"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=5983"}],"version-history":[{"count":2,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5983\/revisions"}],"predecessor-version":[{"id":7218,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5983\/revisions\/7218"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/5986"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=5983"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=5983"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=5983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}